This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lopes, L. M.
Right arrow Articles by Chain, B. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lopes, L. M.
Right arrow Articles by Chain, B. M.

 Previous Article  |  Next Article 

Infection and Immunity, December 2000, p. 6891-6895, Vol. 68, No. 12
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Inhibition of T-cell Response by Escherichia coli Heat-Labile Enterotoxin-Treated Epithelial Cells

Luciene M. Lopes,1 Asher Maroof,1 Gordon Dougan,2 and Benjamin M. Chain1,*

Department of Immunology, Windeyer Institute of Medical Sciences, University College London, London W1P 6DB,1 and Department of Biochemistry, Imperial College of Science, Technology and Medicine, London SW7 2AY,2 United Kingdom

Received 6 March 2000/Returned for modification 16 May 2000/Accepted 25 September 2000

Escherichia coli heat-labile enterotoxin (LT) is an extensively studied adjuvant of mucosal responses. Nevertheless, its mode of action as an adjuvant remains incompletely understood. In this study, we describe a simplified in vitro model with which to look at some aspects of immunoregulation by LT. The interaction of LT with the apical surface of a monolayer of CaCo-2 epithelial cells induces the release of a soluble factor which inhibits the antigen-induced release of interleukin-2 by T cells cultured at the basolateral side of the cells. The release of this factor requires the ADP-ribosylating activity of LT since the isolated B subunit, as well as an enzymatically silent LT mutant, loses biological activity in this model. The inhibitory activity is likely to be due to prostaglandin release, since it is blocked by indomethacin. The contribution of LT-induced prostaglandin release to the complex immunoregulatory activity of LT is discussed.


* Corresponding author. Mailing address: Department of Immunology, Windeyer Institute of Medical Sciences, University College London, 46 Cleveland St., London W1P 6DB, United Kingdom. Phone: 44-20-7679-9402. Fax: 44-20-7679-9357. E-mail: B.CHAIN{at}UCL.AC.UK.


Infection and Immunity, December 2000, p. 6891-6895, Vol. 68, No. 12
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.